dc.contributor.author | Saydam, Faruk | |
dc.contributor.author | Değirmenci, İrfan | |
dc.contributor.author | Birdane, A. | |
dc.contributor.author | Ozdemir, M. | |
dc.contributor.author | Ulus, T. | |
dc.contributor.author | Özbayer, Cansu | |
dc.contributor.author | Çolak, E. | |
dc.contributor.author | Ata, N. | |
dc.contributor.author | Güneş, H.V. | |
dc.date.accessioned | 2020-12-19T19:56:52Z | |
dc.date.available | 2020-12-19T19:56:52Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Saydam, F., Değirmenci, İ., Birdane, A., Özdemir, M., Ulus, T., Özbayer, C., Çolak, E., Ata, N., & Güneş, H. V. (2017). The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. Basic & clinical pharmacology & toxicology, 121(1), 29–36. https://doi.org/10.1111/bcpt.12763 | en_US |
dc.identifier.issn | 0149-2918 | |
dc.identifier.issn | 1879-114X | |
dc.identifier.uri | https://doi.org/10.1016/j.clinthera.2015.05.146 | |
dc.identifier.uri | https://hdl.handle.net/11436/2790 | |
dc.description | 12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics -- JUN 27-30, 2015 -- Madrid, SPAIN | en_US |
dc.description | Ozbayer, Cansu/0000-0002-1120-1874; Colak, Ertugrul/0000-0003-3251-1043 | en_US |
dc.description | WOS: 000384951200135 | en_US |
dc.description.abstract | Background: Clopidogrel inhibits platelet activation and aggregation by blocking the P2Y12 receptor. Dual antiplatelet therapy with
clopidogrel and aspirin is recommended treatment by current guidelines for patients undergoing percutaneous interventions. | en_US |
dc.description.sponsorship | European Assoc Clin Pharmacol & Therapeut | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | The CYP 2C19*2 and CYP2C19*17 polymorphisms play a vital role in platelet responsiveness to clopidogrel after percutaneous coronary intervention: a pharmacogenomic study | en_US |
dc.type | conferenceObject | en_US |
dc.contributor.department | RTEÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
dc.contributor.institutionauthor | Saydam, Faruk | |
dc.contributor.institutionauthor | Güneş, H.V. | |
dc.identifier.doi | 10.1016/j.clinthera.2015.05.146 | |
dc.identifier.volume | 37 | en_US |
dc.identifier.issue | 8 | en_US |
dc.identifier.startpage | E48 | en_US |
dc.identifier.endpage | E48 | en_US |
dc.ri.edit | oa | en_US |
dc.relation.journal | Clinical Therapeutics | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |